Effect of prasugrel on the angiographic parameters of myocardial perfusion

Effect of prasugrel on the angiographic parameters of myocardial perfusion - Effect of prasugrel on the angiographic parameters of myocardial perfusion

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016696

Enrollment

Registered

2015-03-31

Start date

2015-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevation acute myocardial infarction

Interventions

Prasugrel Clopidogrel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: STEMI (< 24 hours from the onset) Primary PCI with informed consent

Exclusion criteria

Exclusion criteria: CPA or recovery from CPA Cardiogenic Shock Culprit lesion was bypass graft or left main trunk No indication for PCI Judgement for inappropriate patients by the doctors

Design outcomes

Primary

Measure	Time frame
Incidence of distal embolization	—

Secondary

Measure	Time frame
Incidence of slow flow, no reflow phenomenon Corrected TIMI frame count Myocardial blush score Maximum value of CK, CK-MB	—

Countries

Japan

Contacts

Public ContactAi Teramoto

Teikyo University Teikyo Academic Research Center

ai.teramoto@med.teikyo-u.ac.jp03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026